Brief: Laurence Lytton Reports 8.8% Passive Stake In Sunesis Pharmaceuticals
Jan 4 (Reuters) - Sunesis Pharmaceuticals Inc SNSS.O :
* LAURENCE LYTTON REPORTS 8.8% PASSIVE STAKE IN SUNESIS
PHARMACEUTICALS INC AS OF DECEMBER 22, 2020 - SEC FILING
Source text : (https://bit.ly/38cXfG4)
Further company coverage: SNSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update